Neos Therapeutics - 8/1/2016
Summary
Neos Therapeutics is a pharmaceutical company that utilizes its modified-release drug delivery platform for the treatment of attention deficit hyperactivity disorder, or ADHD. Subsequently, the drug was launched in the United States in May 2016. The Company also possesses other ADHD assets, Cotempla XR-ODT and NT-0201. Neos Therapeutics is a pharmaceutical company that utilizes its modified-release drug delivery platform for the treatment of attention deficit hyperactivity disorder, or ADHD. The Company also possesses other ADHD assets, Cotempla XR-ODT and NT-0201.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected